Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comparative pharmacologic profile of a glycosaminoglycan mixture, Sulodexide, and a chemically modified heparin derivative, Suleparoide.

× No keyword cloud information.

7 in total

1. Sulodexide promotes arterial relaxation via endothelium-dependent nitric oxide-mediated pathway.

Authors: Joseph D Raffetto; Fiorella Calanni; Paolo Mattana; Raouf A Khalil
Journal: Biochem Pharmacol Date: 2019-04-20 Impact factor: 5.858

2. Comparative Anticoagulant and Thrombin Generation Inhibitory Profile of Heparin, Sulodexide and Its Components.

Authors: Fakiha Siddiqui; Debra Hoppensteadt; Emily Bontekoe; Ambar Farooqui; Walter Jeske; Jawed Fareed
Journal: Clin Appl Thromb Hemost Date: 2020 Jan-Dec Impact factor: 2.389

Review 3. Novel antithrombotic drugs in development.

Authors: M Verstraete; P Zoldhelyi
Journal: Drugs Date: 1995-06 Impact factor: 9.546

4. Anti-proteinuric effect of sulodexide in immunoglobulin a nephropathy.

Authors: Kitae Bang; Ho Jun Chin; Dong Wan Chae; Kwon Wook Joo; Yon Su Kim; Suhnggwon Kim; Kyung Don Ju; Hwajung Kim; Curie Ahn; Kook-Hwan Oh
Journal: Yonsei Med J Date: 2011-07 Impact factor: 2.759

5. Use of sulodexide in patients with peripheral vascular disease.

Authors: J Lasierra-Cirujeda; P Coronel; Mj Aza; M Gimeno
Journal: J Blood Med Date: 2010-06-15

6. Sulodexide Improves Contraction and Decreases Matrix Metalloproteinase-2 and -9 in Veins Under Prolonged Stretch.

Authors: Joseph D Raffetto; Wentao Yu; Xi Wang; Fiorella Calanni; Paolo Mattana; Raouf A Khalil
Journal: J Cardiovasc Pharmacol Date: 2020-03 Impact factor: 3.271

Review 7. Development and use of sulodexide in vascular diseases: implications for treatment.

Authors: Sergio Coccheri; Ferdinando Mannello
Journal: Drug Des Devel Ther Date: 2013-12-24 Impact factor: 4.162

7 in total